Assessing the Preclinical to Clinical Translation of XOlacta

• Analyzing loading efficiency assessment and PK/PD evaluation
• Understanding the IND process for lethal indications
• Overview of clinical assessments of XOlacta

Speakers:

Spencer Marsh

Chief Scientific Officer

The Tiny Cargo Company